[CLDX] YoY Quarter Result on 31-Dec-2009 [#Q4]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
12-Mar-2010
Financial Year
2009
Quarter
31-Dec-2009 [#Q4]
Profit Trend
QoQ- -80.42%
YoY- -73.66%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
Revenue 3,647 2,434 37,721 4,733 2,988 1,720 380 45.72%
PBT -16,807 -12,294 23,046 -13,020 -6,386 -5,254 -6,464 17.24%
Tax -94 268 1,449 -159 -1,444 -314 -252 -15.14%
NP -16,807 -12,732 22,661 -12,943 -7,453 -5,254 -6,212 18.02%
Tax Rate - - -6.29% - - - - -
Total Cost 20,454 15,166 15,060 17,676 10,442 6,974 6,592 20.74%
Ratio Analysis
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
NP Margin -460.84 -523.09 60.08 -273.46 -249.41 -305.49 -1,634.19 -19.00%
Per Share
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
EPS -4.03 -3.81 10.61 -6.13 -7.08 -7.78 -15.04 -19.69%
EPS Diluted -4.03 -3.81 10.61 -6.13 -7.07 -7.78 -14.87 -19.53%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.